Role of multidrug transporters in neurotherapeutics
Acquired resistance to antibiotics and other chemotherapeutic agents is a major problem in the practice of neurology and other branches of medicine. There are several mechanisms by which drug resistance is acquired. Multidrug transporters are important glycoproteins located in the cell membrane that actively transport small lipophilic molecules from one side of the cell membrane to the other, most often from the inside to the outside of a cell. They have important protective role yet may prove inconvenient in chemotherapy. In epilepsy and other disorders this mechanism augments the elimination of drugs from their target cells and leads to drug resistance. In this review, we have discussed the biochemical characteristics of multidrug transporters and the mechanisms by which these membrane bound proteins transport their target molecules from one side to the other side of the cell membrane. We have also briefly discussed the application of this knowledge in the understanding of drug resistance in various clinical situations with particular reference to neurological disorders. These proteins located in the placenta have important role in preventing the transplacental movement of drugs in to the fetus which may result in congenital malformations or other defects. The molecular genetic mechanisms that govern the expression of these important proteins are discussed briefly. The potential scope to develop targeted chemotherapeutic agents is also discussed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2009 |
|---|---|
| Erschienen: |
2009 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Annals of Indian Academy of Neurology - 12(2009), 2 vom: 01. Apr., Seite 89-98 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jose, Manna [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Drug resistant epilepsy |
|---|
| Anmerkungen: |
Date Completed 09.02.2010 Date Revised 20.10.2021 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.4103/0972-2327.53076 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM194974847 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM194974847 | ||
| 003 | DE-627 | ||
| 005 | 20231223201808.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231223s2009 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4103/0972-2327.53076 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0650.xml |
| 035 | |a (DE-627)NLM194974847 | ||
| 035 | |a (NLM)20142853 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jose, Manna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Role of multidrug transporters in neurotherapeutics |
| 264 | 1 | |c 2009 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.02.2010 | ||
| 500 | |a Date Revised 20.10.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Acquired resistance to antibiotics and other chemotherapeutic agents is a major problem in the practice of neurology and other branches of medicine. There are several mechanisms by which drug resistance is acquired. Multidrug transporters are important glycoproteins located in the cell membrane that actively transport small lipophilic molecules from one side of the cell membrane to the other, most often from the inside to the outside of a cell. They have important protective role yet may prove inconvenient in chemotherapy. In epilepsy and other disorders this mechanism augments the elimination of drugs from their target cells and leads to drug resistance. In this review, we have discussed the biochemical characteristics of multidrug transporters and the mechanisms by which these membrane bound proteins transport their target molecules from one side to the other side of the cell membrane. We have also briefly discussed the application of this knowledge in the understanding of drug resistance in various clinical situations with particular reference to neurological disorders. These proteins located in the placenta have important role in preventing the transplacental movement of drugs in to the fetus which may result in congenital malformations or other defects. The molecular genetic mechanisms that govern the expression of these important proteins are discussed briefly. The potential scope to develop targeted chemotherapeutic agents is also discussed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Drug resistant epilepsy | |
| 650 | 4 | |a P-glycoprotein | |
| 650 | 4 | |a multidrug resistance | |
| 650 | 4 | |a multidrug resistance protein | |
| 650 | 4 | |a teratogenic effect | |
| 650 | 4 | |a transport proteins | |
| 700 | 1 | |a Thomas, Sanjeev V |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of Indian Academy of Neurology |d 2008 |g 12(2009), 2 vom: 01. Apr., Seite 89-98 |w (DE-627)NLM192648853 |x 0972-2327 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2009 |g number:2 |g day:01 |g month:04 |g pages:89-98 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4103/0972-2327.53076 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2009 |e 2 |b 01 |c 04 |h 89-98 | ||